CION Ameerpet
Pancreatic Cancer · Hereditary & Genetics · Reviewed by CION Oncologists
Genetic counselling for pancreatic cancer risk — what happens before any test is done
Being sent for genetic counselling is not the same as being told you carry a faulty gene. Counselling is the conversation that comes first — mapping your family, working out whether an inherited pattern is plausible at all, and making sure you know what each possible result would mean before a single sample is taken. Most pancreatic cancer is not inherited, and this page explains how that is actually worked out.
- The conversation comes before the test — and for many families it ends there, because the pattern does not suggest an inherited cause.
- Most pancreatic cancer is not inherited — counselling is how the minority that is gets told apart from the rest.
- A result belongs to the whole family — so who would need to know, and how, is discussed before the sample, not after the report.
- Counselling is in-house at CION — across 35+ centres, with the germline analysis run at an accredited genetics laboratory.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres Across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start here
What Genetic Counselling Is — and What It Is Not
People who search genetic counselling pancreatic cancer are rarely asking an abstract question. Either a parent, a sibling or an aunt has been diagnosed and they want to know whether they are next in line, or they have been diagnosed themselves and a doctor has raised the word “genetics” without explaining much. Both are sensible reasons to sit down with someone. Neither means anyone thinks you carry a faulty gene.
Genetic counselling is a conversation, not a blood test. In it, your family is mapped in detail — both sides, across three generations, which cancers appeared and how old each person was when they did. The pattern is then weighed against the inherited syndromes known to involve the pancreas. You are told which genes are relevant, what a test can and cannot settle, and what each possible result would mean for your own care and for your relatives. Only after that is testing offered. It may follow. It does not have to.
Most pancreatic cancer is not inherited. A minority is linked to a gene change carried through a family, and a further group clusters in families without any gene change ever being found. Counselling is how those three situations are told apart, and the honest answer for many people is that the pattern in their family does not suggest an inherited cause at all. That answer is worth hearing from someone who has actually looked at the pedigree, rather than assumed it either way.
There are two doors into this appointment. The first is a person already diagnosed with pancreatic cancer, where a germline result can occasionally bring a specific systemic option into the discussion, and always gives the family something concrete to act on. The second is a relative who has not been diagnosed and wants to know whether their own risk is genuinely raised, and whether anything should be watched. The conversation looks different in each case, but the structure of it is the same.
If you want the wider picture before the genetics detail, start with our complete guide to pancreatic cancer. If you have already had the counselling conversation and now want the specifics of eligibility, panels and what the laboratory actually reads, germline genetic testing for pancreatic cancer covers that ground. This page stays on the conversation itself, because that is the part almost nobody is told about in advance.
Did you know? NCCN guidance recommends that germline testing be considered for everyone diagnosed with pancreatic adenocarcinoma, regardless of family history or the age at which it was found — and, just as importantly, that it be carried out with pre-test and post-test genetic counselling rather than ordered as a standalone laboratory investigation. The same guidance recommends that a detailed family history be taken and reviewed, and that where a pathogenic germline variant is confirmed, at-risk relatives are offered testing in their own right. That second half is the part most often skipped. A germline result is family information as much as personal information, which is why the conversation about who would need to know happens before the sample is taken, not after the report arrives.
Inside the appointment
What the Counselling Appointment Actually Covers
Not an exhaustive list, but it gives an honest sense of what the time is spent on — and how little of it is about the test itself.
Your family tree
Both sides, three generations
Who had which cancer, how old they were when it was found, and how they are related to you. Breast, ovarian, bowel, prostate, skin and stomach cancers matter here too, because several inherited syndromes span more than one organ.
Which genes
Not one gene — a group of them
BRCA1, BRCA2, PALB2, ATM and CDKN2A are the changes most often discussed alongside pancreatic cancer, together with the mismatch-repair genes behind Lynch syndrome, and the inherited conditions behind Peutz-Jeghers syndrome and hereditary pancreatitis.
Before you consent
What each possible result would mean
A positive, a negative and a variant of uncertain significance are all explained in advance, so that no result arrives as a surprise. The middle one — a change whose meaning is not yet established — is the outcome people are least prepared for.
Your relatives
Who would need to know, and how
If a gene change is confirmed in you, siblings, children and parents each have a reason to be offered testing of their own. Who you would tell, in what order, and what support exists for that conversation is discussed before the sample, not afterwards.
Your own treatment
What a result could change for you
For someone already diagnosed, a germline result can widen what is on the table — but the decision belongs to your treating team. Our pancreatic cancer specialists in Hyderabad take it with your scans and pathology, not from a laboratory report alone.
The limits
What a test cannot tell you
A negative result does not mean no risk. It means no change was found on the genes examined. Where the family history is strong and nothing is found, that history still counts, and the plan is built around it rather than quietly dropped.
Come prepared
What to Bring, and What to Ask
- Who in your family had cancer, and which cancer. Both sides. Aunts, uncles, grandparents and cousins count, not only parents and siblings.
- Roughly how old each relative was at diagnosis. A young diagnosis carries more weight in this assessment than the sheer number of relatives affected.
- Any genetic report already in the family. If a relative has been tested, bring the actual report — a known change in the family completely changes what needs testing in you.
- Your own pathology, if you have been diagnosed. Biopsy or resection reports, and any tumour testing already done, so that nothing is repeated unnecessarily.
- Ask what the test would and would not cover. Germline genetic testing for pancreatic cancer sets out who is offered a test and what a panel includes.
- Ask what happens if the result is uncertain. A variant of uncertain significance is not a diagnosis, is not acted on as though it were, and can be reclassified later.
- Ask what surveillance would follow a confirmed gene change, and who runs it. MRI and blood tests are arranged in-house; endoscopic ultrasound is coordinated with partner endoscopy units and may be billed there.
- Ask who pays for what, in writing. Our genetic counselling service page explains how the counselling sits alongside the laboratory analysis, and where each part of the cost falls.
You do not need a referral, and you do not need to have decided anything before you come. If pancreatic cancer has appeared more than once in your family, one conversation is usually enough to tell you whether it needs looking into at all. Book a free consultation or call 1800 202 8726.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Family History Is a Question, Not a Verdict
Counselling is how that question gets answered properly, before anyone is tested.
The sequence
How the Counselling Pathway Runs at CION
-
The first conversation, and nothing else
A free 45-minute consultation. Your family history is taken properly — both sides, with names, cancers and roughly what age each person was. Nothing is tested on the day, and nobody is asked to decide anything in the room.
In-house at CION -
Whether an inherited pattern is plausible at all
The pedigree is weighed against the syndromes known to involve the pancreas. Sometimes the honest answer is that the pattern does not suggest an inherited cause, and that is said plainly rather than softened into a test nobody needed.
In-house at CION -
Pre-test counselling and consent
What a positive, a negative and an uncertain result would each mean, for you and for your relatives. What would change in your care, and what would not. Testing is voluntary, and declining it is a legitimate answer that is respected.
In-house at CION -
The sample, and the analysis
Usually a blood sample, occasionally saliva. The germline analysis itself is run at an accredited genetics laboratory rather than on site, so that part of the cost sits with the laboratory. We arrange it, chase it and receive the report.
Laboratory analysis coordinated with accredited genetics laboratory partners -
The result, explained in person
Post-test counselling is a separate appointment, not a phone call. You are told what the report says, what it does not say, and what happens next — and you are given a written summary you can hand to a relative or another doctor.
In-house at CION -
What follows, for you and for your family
For a patient under treatment, the result goes back to your medical oncologist. For an unaffected carrier, a surveillance conversation. For relatives, testing for the one known change, arranged through our genetic counselling service.
In-house at CION; surveillance endoscopy coordinated with partners
Be clear about this
What CION Does In-House, and What Is Coordinated
A genetics pathway involves more than one team. This is the honest split, so you know who to call and where each part of the bill sits.
| Part of your care | Where it happens | What that means for you |
|---|---|---|
| The free 45-minute consultation and family-history assessment | In-house at CION | Taken and drawn out by our team, across 35+ centres in Telangana and Andhra Pradesh. |
| Genetic counselling before and after testing, and consent | In-house at CION | Delivered by us as a structured conversation, not a form handed over with a request slip. |
| The germline laboratory analysis itself | Run at an accredited genetics laboratory | Arranged and chased by us; that part of the cost sits with the laboratory, not with us. |
| Reading the report and explaining it to you | In-house at CION | A separate appointment, with a written summary you can share with relatives or another doctor. |
| Pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods | In-house at CION | Ordered, performed and reported by us, including where inherited-risk surveillance is agreed. |
| Endoscopic ultrasound, used in inherited-risk surveillance | Coordinated with gastroenterology and endoscopy partners | Arranged and scheduled by us, performed at a partner unit, and may be billed there. |
| Chemotherapy, PARP-class maintenance, MSI immunotherapy, radiation and SBRT | In-house at CION | Where a result changes what is available to you, that treatment is delivered by our own teams. |
| All pancreatic surgery, ERCP and stenting, staging laparoscopy, coeliac plexus block, PET-CT and DOTATATE PET, and PRRT | Coordinated with specialist HPB, gastroenterology, endoscopy and nuclear medicine partners | Arranged by us, performed at partner centres, and may be billed there. |
| Nutrition, enzyme (PERT) support, pain, psycho-oncology and survivorship follow-up | In-house at CION | Available throughout, including for the anxiety a family result can bring with it. |
If you are weighing up whether to test at all, ask for that split in writing before you consent. Our genetic counselling service sets out what the counselling covers, and our pancreatic cancer doctors are the ones who act on the result.
The part that comes later
After the Result — For You, and For Your Family
A confirmed gene change does not mean cancer, and it is not a prediction. It means a known susceptibility has been identified, and that there is now something specific to act on. For you, that usually opens a conversation about surveillance — whether it is appropriate at all, what it would involve, and how often. For your relatives, it means their own test is far simpler than yours was, because the laboratory is looking for one known change rather than reading a whole panel. That is usually called cascade testing, and it is the single most useful thing a positive result produces.
A negative result is not the same as no risk. If several close relatives have had pancreatic cancer and nothing is found on testing, the family history has not gone away — it simply has no named explanation yet. In that situation the plan is built around the history itself, and the file stays open, because panels and variant classifications are revised over time and a report read today may read differently in a few years.
Surveillance is worth being plain about, because it is often misunderstood as a scan anyone can request. It is not a general screening programme, it is not offered to the population at large, and CA 19-9 is not a screening test for people without symptoms. Structured monitoring is considered only for people with a confirmed inherited susceptibility or a genuinely strong familial pattern, and where it is offered it usually combines MRI with endoscopic ultrasound. The MRI and the blood work are ours; the endoscopic ultrasound is coordinated with partner endoscopy units and may be billed there.
The commitment on our side is the same one we make everywhere else. No rushed decisions, and no unnecessary tests. If the pattern in your family does not warrant testing, we will say so and explain why, rather than ordering a panel because it is quicker than having the conversation. If it does warrant testing, you will understand exactly what you are consenting to before you sign it.
Bring the family details, not only the worry — names, cancers, and roughly what age each person was. A 45-minute conversation is usually enough to tell you where you actually stand. Book a free consultation or call 1800 202 8726.
Take the next step
You Deserve a Clear Answer About Your Family Risk
From the first family-history conversation to what your relatives are told, we walk this journey with you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Genetic counselling for pancreatic cancer — your questions answered
Is genetic counselling the same thing as a genetic test?
No. Genetic counselling is a conversation; the test is optional, and it comes afterwards if at all. In the appointment your family history is mapped in detail across both sides and three generations, the pattern of cancers and the ages at which they appeared is assessed, and the genes relevant to the pancreas are explained. You are then told what each possible result would mean, for your own care and for your relatives, before anything is sent to a laboratory. Many people leave that conversation with a clear answer and no test at all, because the pattern does not suggest an inherited cause. Others leave with a test arranged and a realistic idea of what the report will and will not settle. The counselling is the part that makes the test worth doing.
Who should be referred for genetic counselling about pancreatic cancer?
Broadly two groups. The first is anyone already diagnosed with pancreatic adenocarcinoma, because NCCN guidance supports considering germline testing in that situation regardless of family history, and counselling is how that decision gets made properly rather than by default. The second is a person who has not been diagnosed but has pancreatic cancer in the family, particularly where more than one close relative has been affected, where someone was diagnosed unusually young, or where the family also carries breast, ovarian, bowel, skin or stomach cancers that can travel with the same inherited syndromes. A gene change already confirmed in a relative is another clear reason, and the simplest one to act on. Our page on germline genetic testing for pancreatic cancer sets out eligibility in more detail; counselling is the step before it.
Why does the counselling happen before the test rather than after it?
Because a germline result is difficult to un-know, and it is family information as much as personal information. Before a sample is taken you need to understand three things: what a positive result would mean for your own care and any surveillance, what it would mean for your siblings, children and parents, and what an uncertain result would mean, since a variant whose significance is not yet established is a common outcome and is not acted on as though it were a diagnosis. Thinking all of that through calmly in advance is a very different experience from being handed a report and asked to absorb it on the spot. Counselling afterwards still happens, and still matters, but the useful thinking is done first.
What are the possible results, and what does each one actually mean?
There are three. A pathogenic or likely pathogenic variant means a gene change known to raise cancer risk has been found; that can affect surveillance, sometimes treatment, and it gives relatives something specific to be tested for. A negative result means no change was found on the genes examined, which is not the same as no risk and does not cancel out a strong family history. A variant of uncertain significance means a change was found but its meaning is not yet established; it is not treated as a diagnosis, no decision is based on it, and its classification can be revised later as more data accumulates. All three outcomes are explained to you before you consent, so that none of them arrives as a shock.
If I carry a gene change, what does that mean for my children and siblings?
It means each of them has a reason to be offered testing in their own right, which is usually called cascade testing. Because a specific change has already been identified in the family, their test is simpler and far more definitive than yours was: the laboratory is looking for one known thing rather than reading a whole panel. A relative who does not carry it is generally returned to ordinary population risk for that gene. A relative who does carry it can then have their own counselling conversation about what, if anything, should be monitored, and when. Who to tell, in what order, and how, is part of the counselling rather than something you are left to work out alone, and you are given a written summary you can share.
Will a genetic result change my own treatment if I already have pancreatic cancer?
It can, which is why germline testing is now considered for everyone diagnosed with pancreatic adenocarcinoma rather than only for those with a family history. Where a BRCA-type change is confirmed, PARP-inhibitor-class maintenance becomes a considered option for some people after a course of combination chemotherapy. Where a tumour is found to be mismatch-repair deficient, immune checkpoint treatment enters the discussion. Neither is automatic, and neither is decided by a laboratory report on its own; the decision belongs to your treating medical oncologist, taken alongside your scans, your pathology and how you are actually doing. What the result reliably does is make sure a possible option is not quietly missed, and give your family something concrete to act on.
What does CION do, and what happens at the first visit?
Genetic counselling is delivered in-house at CION, across a network of 35+ centres in Telangana and Andhra Pradesh, and the first consultation is free and lasts 45 minutes. Nothing is tested on the day. We take a detailed family history across both sides, look at the pattern rather than only the number of relatives affected, and say plainly whether testing is likely to add anything. If it is, the pre-test conversation, the consent and the result appointment all happen with us; the germline analysis itself is run at an accredited genetics laboratory and that part may be billed there. Imaging, CA 19-9 and bloods, medical and radiation oncology, nutrition, pain and psycho-oncology are in-house. Endoscopic ultrasound, ERCP and stenting, PET-CT and all pancreatic surgery are coordinated with specialist partner centres and may be billed there.
Medical disclaimer: This page explains what genetic counselling for pancreatic cancer risk involves and is reviewed by a CION medical oncologist with reference to NCCN guidance on genetic and familial risk assessment and on pancreatic adenocarcinoma. It is general information and not a risk assessment for any individual; whether testing is appropriate for you depends on your own family history and diagnosis, and must be decided with a clinician who has seen both. Genetic counselling before and after testing, consent and result interpretation, pancreatic-protocol CT, MRI/MRCP, CA 19-9 and bloods, medical and radiation oncology, nutrition and enzyme (PERT) support, pain, psycho-oncology and survivorship care are delivered by CION. The germline laboratory analysis itself is performed at an accredited genetics laboratory, and endoscopic ultrasound and biopsy, ERCP and biliary stenting, staging laparoscopy, coeliac plexus block, PET-CT and DOTATATE PET, peptide receptor radionuclide therapy and all pancreatic surgery are coordinated with specialist HPB, gastroenterology, endoscopy and nuclear medicine partner centres and may be billed there.